【24h】

Real Time Laser Speckle Imaging Monitoring Vascular Targeted Photodynamic Therapy

机译:实时激光散斑成像监测血管靶向光动力治疗

获取原文

摘要

Laser speckle imaging is a technique that has been developed to non-invasively monitor in vivo blood flow dynamics and vascular structure, at high spatial and temporal resolution. It can record the full-field spatio-temporal characteristics of microcirculation and has therefore, often been used to study the blood flow in tumors after photodynamic therapy (PDT). Yet, there is a paucity of reports on real-time laser speckle imaging (RTLSI) during PDT. Vascular-targeted photodynamic therapy (VTP) with WST11, a water-soluble bacteriochlorophyll derivative, achieves tumor ablation through rapid occlusion of the tumor vasculature followed by a cascade of events that actively kill the tumor cells. WST11-VTP has been already approved for treatment of early/intermediate prostate cancer at a certain drug dose, time and intensity of illumination. Application to other cancers may require different light dosage. However, incomplete vascular occlusion at lower light dose may result in cancer cell survival and tumor relapse while excessive light dose may lead to toxicity of nearby healthy tissues. Here we provide evidence for the feasibility of concomitant RTLSI of the blood flow dynamics in the tumor and surrounding normal tissues during and after WST11-VTP. Fast decrease in the blood flow is followed by partial mild reperfusion and a complete flow arrest within the tumor by the end of illumination. While the primary occlusion of the tumor feeding arteries and draining veins agrees with previous data published by our group, the late effects underscore the significance of light dose control to minimize normal tissue impairment. In conclusion- RTSLI application should allow to optimize VTP efficacy vs toxicity in both the preclinical and clinical arenas.
机译:激光散斑成像是一种技术,该技术已经开发成在高空间和时间分辨率下以体内血流动力学和血管结构进行非侵入性监测。它可以记录微循环的全场时空特征,因此,通常用于在光动力治疗(PDT)之后研究肿瘤中的血液流动。然而,PDT期间存在关于实时激光散斑成像(RTLSI)的报告。具有WST11的血管靶向光动力治疗(VTP),一种水溶性菌氯苯基衍生物,通过快速闭塞肿瘤烧蚀,然后通过激活杀死肿瘤细胞的级联。 WST11-VTP已经批准以某种药物剂量,时间和照明强度治疗早期/中间前列腺癌。施用于其他癌症可能需要不同的光剂量。然而,较低光剂量的不完全血管闭塞可能导致癌细胞存活和肿瘤复发,同时过度光剂量可能导致附近健康组织的毒性。在这里,我们提供了在WST11-VTP期间和之后携带肿瘤中血流动力学的血流动力学的伴随血液流动动力学的可行性证据。血流的快速降低随后通过照射结束,血液中的部分温和再灌注和在肿瘤内完全流动。虽然肿瘤喂养动脉和排水静脉的主要闭塞同意我们本集团出版的先前数据,但晚期效果强调了光剂量控制的重要性,以最大限度地减少正常组织损伤。结论 - RTSLI应用应该允许在临床前和临床竞技中优化VTP疗效与毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号